How L’Oréal’s 20 Percent Stake in Galderma Positions both groups for the Next Skin Health Boom

Deal terms and board shift The new 10% stake builds on L’Oréal’s initial investment made in August 2024, turning a minority position into a more strategic anchor in Galderma’s long-term growth story.

Once completed, L’Oréal will own 20% of Galderma, strengthening its foothold in premium dermatology at a time when consumers are investing more in targeted skin health solutions.

In connection with the increased investment, Galderma will consider nominating two non-independent board candidates from L’Oréal at its 2026 Annual General Meeting, replacing board members representing the selling consortium.

This board evolution aligns governance more closely with L’Oréal’s strategic priorities and reinforces collaboration on portfolio, innovation, and global expansion. Science-first partnership Beyond capital, the tie-up also extends to innovation…